COMMUNIQUÉS West-GlobeNewswire

Aino Health AB (publ): Notice of annual general meeting of aino health ab (publ)
26/04/2018
April 26, 2018 Notice of annual general meeting of aino health ab (publ) Shareholders in Aino Health AB (publ), company reg. no. 559063-5073 ("the Company") are hereby notified of the Annual General Meeting which will [...]
Enzymatica AB: Continued growth during the first quarter
26/04/2018
Interim report for Enzymatica AB (publ) JANUARY- MARCH 2018 Continued growth during the first quarter First quarter Net sales reached SEK 15.1 (9.6) million. Net profit after tax came in at SEK -10.1 (-11.4) million. [...]
C-RAD AB – Interim report January-March 2018
26/04/2018
CONTINUED STRONG GROWTH, REVENUE INCREASED BY 31 PERCENT JANUARY - MARCH 2018 Order intake: 50.6 (40.2) MSEK, 26%. Revenues: 33.8 (25.8) MSEK, 31%. Operating profit: -4.7 (-5.7) MSEK. Net results after tax: -4.9 (-5.8) [...]
Shire plc : Rule 2.9 Announcement
26/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 26 April 2018 [...]
Financière de Tubize SA: Approval of dividend
26/04/2018
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, general manager, aspijcke@icloud.com Approval of dividend Regulated information 25 April 2018 The general [...]
Financière de Tubize SA: Approbation du dividende
26/04/2018
Communiqué de presse FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: aspijcke, directeur, aspijcke@icloud.com Approbation du dividende Information réglementée 25 avril 2018 L'assemblée générale [...]
Saniona progress to second part of Phase 2a study for Tesomet in Prader-Willi Syndrome based on positive results in adult patients
26/04/2018
PRESS RELEASE April 26, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has obtained approval to initiate the second part of its Phase 2a trial for Tesomet in adolescents [...]
Bone Therapeutics SA : Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director
26/04/2018
Press release Bone Therapeutics Strengthens Board with the Appointment of Claudia D'Augusta as Non-Executive Director Claudia D'Augusta brings significant financial and capital markets experience Gosselies, Belgium, 26 [...]
Bone Therapeutics SA étoffe son Conseil d'administration avec la nomination de Claudia D'Augusta en tant qu'Administrateur non-exécutif
26/04/2018
Communiqué de presse Bone Therapeutics étoffe son Conseil d'administration avec la nomination de Claudia D'Augusta en tant qu'Administrateur non-exécutif Claudia D'Augusta apporte une expérience significative des [...]
Vistin Pharma ASA : Delivers 22% revenue growth in first quarter 2018
26/04/2018
Oslo, Norway, 26 April 2018 Vistin Pharma ASA delivers a revenue growth of 22 percent from NOK 43.4 million in the first quarter 2017 to NOK 52.8 million in the first quarter 2018. The underlying demand for metformin is [...]
MDxHealth Announces Positive Clinical Updates for ConfirmMDx
26/04/2018
NEWS RELEASE REGULATED INFORMATION MDxHealth Announces Positive Clinical Updates for ConfirmMDx ConfirmMDx included in the 2018 EAU Guidelines for Prostate Cancer Publication of ConfirmMDx Validation Study in African [...]
MDxHealth annonce des mises à jour cliniques positives pour ConfirmMDx
26/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES MDxHealth annonce des mises à jour cliniques positives pour ConfirmMDx ConfirmMDx inclus dans les directives 2018 émises par l'EAU pour le cancer de la prostate Publication [...]
Biocartis Group NV: BIOCARTIS Q1 2018 BUSINESS UPDATE
26/04/2018
PRESS RELEASE: REGULATED INFORMATION Thursday, 26 April 2018, 07:00 CEST BIOCARTIS Q1 2018 BUSINESS UPDATE Mechelen, Belgium , 26 April 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
26/04/2018
Company announcement - No. 12/2018 Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome Glepaglutide is in development as a new treatment option for patients with short [...]
Medibio Announces Scientific Advisory Board
26/04/2018
Led by Board of Director Franklyn Prendergast, M.D., Ph.D. and Chief Medical Officer Archie Defillo, M.D. Key external members include Martin Chapman, M.D.; Joel Ehrenkranz, M.D.; Mark A. Frye, M.D.; Lawrence Hunter, Ph [...]
Western Canadian Cannabis Use: Proprietary Study Indicates Half of Western Canadians Are Cannabis Users, Lapsed Users, or Interested in Trying Cannabis
26/04/2018
EDMONTON, Alberta, April 25, 2018 (GLOBE NEWSWIRE) -- Modern Leaf, an industry leading cannabis education and e-commerce platform, recently commissioned a research study of 2,005 Western Canadians from Manitoba, [...]
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
26/04/2018
WALTHAM, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price [...]
Nextech to Showcase Enhanced Cloud-Based Technology at The Aesthetic Meeting 2018
25/04/2018
Full suite of Electronic Medical Record and Practice Management solutions now include new reporting and mobility functionalities for plastic surgeons TAMPA, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a [...]
Dentsply Sirona Declares Quarterly Cash Dividend
25/04/2018
YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]

Pages